These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26106218)

  • 21. Controlled release of stromal cell-derived factor-1 alpha in situ increases c-kit+ cell homing to the infarcted heart.
    Zhang G; Nakamura Y; Wang X; Hu Q; Suggs LJ; Zhang J
    Tissue Eng; 2007 Aug; 13(8):2063-71. PubMed ID: 17518719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating the role of autologous mesenchymal stem cell seeded on decellularized pericardium in the treatment of myocardial infarction: an animal study.
    Kajbafzadeh AM; Tafti SHA; Khorramirouz R; Sabetkish S; Kameli SM; Orangian S; Rabbani S; Oveisi N; Golmohammadi M; Kashani Z
    Cell Tissue Bank; 2017 Dec; 18(4):527-538. PubMed ID: 28528367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thymosin β4 increases the potency of transplanted mesenchymal stem cells for myocardial repair.
    Ye L; Zhang P; Duval S; Su L; Xiong Q; Zhang J
    Circulation; 2013 Sep; 128(11 Suppl 1):S32-41. PubMed ID: 24030419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of human mesenchymal stem cell function in a three-dimensional matrix promotes attenuation of adverse remodelling after myocardial infarction.
    Simpson DL; Dudley SC
    J Tissue Eng Regen Med; 2013 Mar; 7(3):192-202. PubMed ID: 22095744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human cord blood mononuclear cells decrease cytokines and inflammatory cells in acute myocardial infarction.
    Henning RJ; Shariff M; Eadula U; Alvarado F; Vasko M; Sanberg PR; Sanberg CD; Delostia V
    Stem Cells Dev; 2008 Dec; 17(6):1207-19. PubMed ID: 18393684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteogenic potential of human umbilical cord-derived mesenchymal stromal cells cultured with umbilical cord blood-derived fibrin: a preliminary study.
    Baba K; Yamazaki Y; Ishiguro M; Kumazawa K; Aoyagi K; Ikemoto S; Takeda A; Uchinuma E
    J Craniomaxillofac Surg; 2013 Dec; 41(8):775-82. PubMed ID: 23465638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incremental benefits of repeated mesenchymal stromal cell administration compared with solitary intervention after myocardial infarction.
    Richardson JD; Psaltis PJ; Frost L; Paton S; Carbone A; Bertaso AG; Nelson AJ; Wong DT; Worthley MI; Gronthos S; Zannettino AC; Worthley SG
    Cytotherapy; 2014 Apr; 16(4):460-70. PubMed ID: 24113430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Embryonic stem cells cultured in biodegradable scaffold repair infarcted myocardium in mice.
    Ke Q; Yang Y; Rana JS; Chen Y; Morgan JP; Xiao YF
    Sheng Li Xue Bao; 2005 Dec; 57(6):673-81. PubMed ID: 16344890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct implantation versus platelet-rich fibrin-embedded adipose-derived mesenchymal stem cells in treating rat acute myocardial infarction.
    Sun CK; Zhen YY; Leu S; Tsai TH; Chang LT; Sheu JJ; Chen YL; Chua S; Chai HT; Lu HI; Chang HW; Lee FY; Yip HK
    Int J Cardiol; 2014 May; 173(3):410-23. PubMed ID: 24685001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CXCR4 Antagonist TG-0054 Mobilizes Mesenchymal Stem Cells, Attenuates Inflammation, and Preserves Cardiac Systolic Function in a Porcine Model of Myocardial Infarction.
    Hsu WT; Jui HY; Huang YH; Su MY; Wu YW; Tseng WY; Hsu MC; Chiang BL; Wu KK; Lee CM
    Cell Transplant; 2015; 24(7):1313-28. PubMed ID: 24823505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human cord blood cells induce angiogenesis following myocardial infarction in NOD/scid-mice.
    Ma N; Stamm C; Kaminski A; Li W; Kleine HD; Müller-Hilke B; Zhang L; Ladilov Y; Egger D; Steinhoff G
    Cardiovasc Res; 2005 Apr; 66(1):45-54. PubMed ID: 15769447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concomitant Retrograde Coronary Venous Infusion of Basic Fibroblast Growth Factor Enhances Engraftment and Differentiation of Bone Marrow Mesenchymal Stem Cells for Cardiac Repair after Myocardial Infarction.
    Wang X; Zhen L; Miao H; Sun Q; Yang Y; Que B; Lopes Lao EP; Wu X; Ren H; Shi S; Lau WB; Ma X; Ma C; Nie S
    Theranostics; 2015; 5(9):995-1006. PubMed ID: 26155315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamic induction of pro-angiogenic milieu after transplantation of marrow-derived mesenchymal stem cells in experimental myocardial infarction.
    Rahbarghazi R; Nassiri SM; Ahmadi SH; Mohammadi E; Rabbani S; Araghi A; Hosseinkhani H
    Int J Cardiol; 2014 May; 173(3):453-66. PubMed ID: 24679689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transplantation of mesenchymal stem cells carrying the human receptor activity-modifying protein 1 gene improves cardiac function and inhibits neointimal proliferation in the carotid angioplasty and myocardial infarction rabbit model.
    Shi B; Long X; Zhao R; Liu Z; Wang D; Xu G
    Exp Biol Med (Maywood); 2014 Mar; 239(3):356-65. PubMed ID: 24477823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transplantation of umbilical cord blood-derived mesenchymal stem cells as therapy for adriamycin induced-cardiomyopathy.
    Zhang J; Zhang S; Yang Y; Liu L
    Bioengineered; 2022 Apr; 13(4):9564-9574. PubMed ID: 35387551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of TIMP-1 in embryonic stem cells attenuates adverse cardiac remodeling following myocardial infarction.
    Glass C; Singla DK
    Cell Transplant; 2012; 21(9):1931-44. PubMed ID: 22449760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective inhibition of inositol hexakisphosphate kinases (IP6Ks) enhances mesenchymal stem cell engraftment and improves therapeutic efficacy for myocardial infarction.
    Zhang Z; Liang D; Gao X; Zhao C; Qin X; Xu Y; Su T; Sun D; Li W; Wang H; Liu B; Cao F
    Basic Res Cardiol; 2014 Jul; 109(4):417. PubMed ID: 24847908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of compound danshen dripping pills and human umbilical cord blood mononuclear cell transplant after acute myocardial infarction.
    Jun Y; Chunju Y; Qi A; Liuxia D; Guolong Y
    Exp Clin Transplant; 2014 Apr; 12(2):123-8. PubMed ID: 24702144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Beneficial effects of human umbilical cord blood mononuclear cells transplantation on rats with experimental myocardial infarction].
    Hu CH; Wu GF; Wang XQ; Yang YH; He XH; Du ZM
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jul; 34(7):587-90. PubMed ID: 17081357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracoronary delivery of umbilical cord blood derived unrestricted somatic stem cells is not suitable to improve LV function after myocardial infarction in swine.
    Moelker AD; Baks T; Wever KM; Spitskovsky D; Wielopolski PA; van Beusekom HM; van Geuns RJ; Wnendt S; Duncker DJ; van der Giessen WJ
    J Mol Cell Cardiol; 2007 Apr; 42(4):735-45. PubMed ID: 17320899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.